University of Florida
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).
University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.
University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.
Top-decile sponsor footprint
University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,106 total, page 5 of 23
Tadalafil as Adjuvant Therapy for DMD
NCT05195775
A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
NCT04573140
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness
NCT05006833
The Roles of Gut Microbiome in UTI Susceptible Women
NCT05065008
PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy
NCT04837547
Tazemetostat in Malignant Peripheral Nerve Sheath Tumors
NCT04917042
Automated Imaging Differentiation of Parkinsonism
NCT05913687
AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma
NCT04448002
American Cranberries to Prevent UTIs in Susceptible Women
NCT04626362
Non-invasive Nerve Stimulation and Cognitive Training to Improve Cognitive Performance in Healthy Older Adults
NCT04276805
Augmenting a Post-Stroke Wellness Program With Respiratory Muscle Training
NCT05819333
The Revitalize Study in Older Adults at Risk for Alzheimer's Disease
NCT04018092
Precision PCI Registry
NCT06143709
Lactobacillus Johnsonii Supplementation in Adults With T1D
NCT03961347
Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD
NCT04220021
Functional Endoscopic Sinus Surgery Study
NCT03970655
A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma
NCT03483038
Evaluation of Trigeminal Nerve Blockade
NCT03632044
Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer
NCT03624660
A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer
NCT03561220
Gastric Ultrasound for Estimation of the Aspiration Risk Study
NCT03310528
Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
NCT03405792
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
NCT03417388
Digital Rehabilitation Environment Augmenting Medical System
NCT03385993
Microfluidic Assessment of Clinical Outcomes in Preterm Newborns
NCT03291496
Sepsis Associated Encephalopathy (SAE) Biomarkers
NCT03133208
Responsive Deep Brain Stimulator for Essential Tremor
NCT02649166
Integrating Data, Algorithms and Clinical Reasoning for Surgical Risk Assessment
NCT02741986
Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care and Induced Frailty
NCT02711709
Fundamental Intelligent Building Blocks of the Intensive Care Unit (ICU) of the Future: Intelligent ICU of the Future
NCT03905668
Intelligent Intensive Care Unit
NCT02465307
Network Analysis of Urinary Molecular Signature Complements Clinical Data to Predict Postoperative Acute Kidney Injury
NCT02114138
Selection of a Protective T Cell-based HIV-1/FIV Vaccine
NCT02389595
PICS: Subtitle Cardiac Dysfunction in Older Sepsis Survivors
NCT02276417
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations
NCT07581379
Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events
NCT06855394
Survival of Implant-Supported All-Ceramic Prostheses
NCT01729858
AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function
NCT05432765
Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial
NCT03429413
PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study
NCT07670650
Respiratory Muscle Strength Training to Prevent Respiratory Muscle Weakness in Adults Newly Diagnosed With Breast Cancer
NCT07229378
Assessing Performance of a Hepatitis C Emergency Department (HepC-EnD) Screening Tool: IT Integration Process for Electronic Health Record System
NCT07406490
Alcohol Sensitivity Among Older Adults Who Consume Alcohol
NCT07636447
Effects of Photobiomodulation on Inflammation and Chronic Pain in Knee Osteoarthritis (EPIC-KO)
NCT07079969
IL-8 Receptor Modified Patient-Derived Activated CD70 CAR T Cell Therapy in Adults With Brain Metastases
NCT07569263
High Frequency Stimulation to Improve Cognition, Mobility, and Affect in Individuals With and Without Subjective Cognitive Decline
NCT07395609
Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athletes With Co-morbid Depression and Concussion
NCT07507214
Methylphenidate and Response to Alcohol Cues
NCT07306078
Kava Aging and Mobility Study
NCT07219186
Transcutaneous Vagus Nerve Stimulation (tVNS) and Stress Regulation During Performance Tasks
NCT07470229
What is open in the University of Florida pipeline
170 recruiting of 1,106 indexed (15% open); 754 completed (68%).
Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Florida: open-pipeline peers nationwide
Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,106 trials (± recruiting share)
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this University of Florida page
1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.
- 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Florida pipeline card: 1,106 registered trials from official public datasets.Report a data error.